| Literature DB >> 20082956 |
Carlos Ferrándiz1, Jose Manuel Carrascosa, Aram Boada.
Abstract
During the last 30 years, the tremendous progress in our knowledge of the pathogenesis of psoriasis has led to the development of new agents, the so-called biologics, that have revolutionized the management of severe psoriasis. Dermatologists and patients see this emerging therapy as a new perspective in the state of the art in managing moderate to severe psoriasis. After a few years of use in daily practice, we may begin to analyze the power of the currently available biologic agents in the management of severe psoriasis from the perspective of facts. Copyright 2010 Elsevier Inc. All rights reserved.Entities:
Mesh：
Substances：
Year: 2010 PMID： 20082956 DOI： 10.1016/j.clindermatol.2009.03.002
Source DB: PubMed Journal: Clin Dermatol ISSN： 0738-081X Impact factor: 3.541